Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	353 Pages	The Business Research Company	September, 2024	BRC19156998

Best Price Guarantee
Price	from $5,000
Length	353 Pages
Publisher	The Business Research Company
Published Date	September, 2024
SKU	BRC19156998

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033

Including: 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMérieux SA.; Danaher Corporation (Cepheid, Inc.)

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by test type, by disease stage and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tuberculosis diagnostics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by test type, by disease stage and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types

2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis

3) By End User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research Facilities

Companies Mentioned: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMérieux SA.; Danaher Corporation (Cepheid, Inc.)

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Tuberculosis Diagnostics – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Tuberculosis Diagnostics Market Definition And Segmentations; 6.4 Market Segmentation By Test Type; 6.4.1 Radiographic Test; 6.4.2 Nucleic Acid Testing; 6.4.3 Cytokine Detection Test; 6.4.4 Drug Resistance Test; 6.4.5 Skin Test/Mantoux Test (TST); 6.4.6 Blood Test/Serology Test; 6.4.7 Smear Microscopy; 6.4.8 Cultured-Based Tests; 6.4.9 Other Test Types; 6.5 Market Segmentation By Disease Stage; 6.5.1 Latent Tuberculosis; 6.5.2 Active Tuberculosis; 6.6 Market Segmentation By End-User; 6.6.1 Hospitals And Diagnostic Laboratories; 6.6.2 Physician’s Office Laboratories; 6.6.3 Reference Laboratories; 6.6.4 Academics And Research Facilities
7 Major Market Trends: 7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics; 7.2 New Product Innovations For Advanced Diagnostics Solutions; 7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability; 7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy; 7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings; 7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics; 7.7 Technology Advancements To Transform The Landscape Of TB Detection; 7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB
8 Tuberculosis Diagnostics Market – Macro-Economic Scenario: 8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market; 8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market; 8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market
9 Global Market Size and Growth: 9.1 Market Size; 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million); 9.2.1 Market Drivers 2018 – 2023; 9.2.2 Market Restraints 2018 – 2023; 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million); 9.3.1 Market Drivers 2023 – 2028; 9.3.2 Market Restraints 2023 – 2028
10 Global Tuberculosis Diagnostics Market Segmentation: 10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Tuberculosis Diagnostics Market, Regional and Country Analysis: 11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market: 12.1 Summary; 12.1.1 Market Overview; 12.1.2 Region Information; 12.1.3 Market Information; 12.1.4 Background Information; 12.1.5 Government Initiatives; 12.1.6 Regulations; 12.1.7 Regulatory Bodies; 12.1.8 Major Associations; 12.1.9 Taxes Levied; 12.1.10 Corporate Tax Structure; 12.1.11 Investments; 12.1.12 Major Companies; 12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis; 12.6 China Market; 12.7 Summary; 12.7.1 Market Overview; 12.7.2 Country Information; 12.7.3 Market Information; 12.7.4 Background Information; 12.7.5 Government Initiatives; 12.7.6 Regulations; 12.7.7 Regulatory Bodies; 12.7.8 Major Associations; 12.7.9 Taxes Levied; 12.7.10 Corporate Tax Structure; 12.7.11 Investments; 12.7.12 Major Companies; 12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.11 India Market; 12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.15 Japan Market; 12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.19 Australia Market; 12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.23 Indonesia Market; 12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.27 South Korea Market; 12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market: 13.1 Summary; 13.1.1 Market Overview; 13.1.2 Region Information; 13.1.3 Market Information; 13.1.4 Background Information; 13.1.5 Government Initiatives; 13.1.6 Regulations; 13.1.7 Regulatory Bodies; 13.1.8 Major Associations; 13.1.9 Taxes Levied; 13.1.10 Corporate Tax Structure; 13.1.11 Investments; 13.1.12 Major Companies; 13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis; 13.6 UK Market; 13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.10 Germany Market; 13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.14 France Market; 13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.18 Italy Market; 13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.22 Spain Market; 13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market: 14.1 Summary; 14.1.1 Market Overview; 14.1.2 Region Information; 14.1.3 Market Information; 14.1.4 Background Information; 14.1.5 Government Initiatives; 14.1.6 Regulations; 14.1.7 Regulatory Bodies; 14.1.8 Major Associations; 14.1.9 Taxes Levied; 14.1.10 Corporate Tax Structure; 14.1.11 Investments; 14.1.12 Major Companies; 14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis; 14.6 Russia Market; 14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market: 15.1 Summary; 15.1.1 Market Overview; 15.1.2 Region Information; 15.1.3 Market Information; 15.1.4 Background Information; 15.1.5 Government Initiatives; 15.1.6 Regulations; 15.1.7 Regulatory Bodies; 15.1.8 Major Associations; 15.1.9 Taxes Levied; 15.1.10 Corporate Tax Structure; 15.1.11 Investments; 15.1.12 Major Companies; 15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.5 North America Tuberculosis Diagnostics Market: Country Analysis; 15.6 USA Market; 15.7 Summary; 15.7.1 Market Overview; 15.7.2 Country Information; 15.7.3 Market Information; 15.7.4 Background Information; 15.7.5 Government Initiatives; 15.7.6 Regulations; 15.7.7 Regulatory Bodies; 15.7.8 Major Associations; 15.7.9 Taxes Levied; 15.7.10 Corporate Tax Structure; 15.7.11 Investments; 15.7.12 Major Companies; 15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.11 Canada Market; 15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market: 16.1 Summary; 16.1.1 Market Overview; 16.1.2 Region Information; 16.1.3 Market Information; 16.1.4 Background Information; 16.1.5 Government Initiatives; 16.1.6 Regulations; 16.1.7 Regulatory Bodies; 16.1.8 Major Associations; 16.1.9 Taxes Levied; 16.1.10 Corporate Tax Structure; 16.1.11 Investments; 16.1.12 Major Companies; 16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.5 South America Tuberculosis Diagnostics Market: Country Analysis; 16.6 Brazil Market; 16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market: 17.1 Summary; 17.1.1 Market Overview; 17.1.2 Region Information; 17.1.3 Market Information; 17.1.4 Background Information; 17.1.5 Government Initiatives; 17.1.6 Regulations; 17.1.7 Regulatory Bodies; 17.1.8 Major Associations; 17.1.9 Taxes Levied; 17.1.10 Corporate Tax Structure; 17.1.11 Investments; 17.1.12 Major Companies; 17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market: 18.1 Summary; 18.1.1 Market Overview; 18.1.2 Region Information; 18.1.3 Market Information; 18.1.4 Background Information; 18.1.5 Government Initiatives; 18.1.6 Regulations; 18.1.7 Regulatory Bodies; 18.1.8 Major Associations; 18.1.9 Taxes Levied; 18.1.10 Corporate Tax Structure; 18.1.11 Investments; 18.1.12 Major Companies; 18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles: 19.1 Company Profiles; 19.2 Becton, Dickinson and Company; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.2.3 Business Strategy; 19.2.4 Financial Overview; 19.3 Qiagen N.V.; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.3.3 Business Strategy; 19.3.4 Financial Overview; 19.4 F. Hoffman-La Roche Ltd; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.4.3 Business Strategy; 19.4.4 Financial Overview; 19.5 BioMerieux SA; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.5.3 Business Strategy; 19.5.4 Financial Overview; 19.6 Danaher Corporation (Cepheid, Inc.); 19.6.1 Company Overview; 19.6.2 Products And Services; 19.6.3 Business Strategy; 19.6.4 Financial Overview
20 Tuberculosis Diagnostics Market Other Major And Innovative Companies: 20.1 Abbott Laboratories, Inc; 20.1.1 Company Overview; 20.1.2 Products And Services; 20.2 Bio-Rad Laboratories, Inc; 20.2.1 Company Overview; 20.2.2 Products And Services; 20.3 Thermo Fisher Scientific, Inc; 20.3.1 Company Overview; 20.3.2 Products And Services; 20.4 PerkinElmer, Inc; 20.4.1 Company Overview; 20.4.2 Products And Services; 20.5 Bio-Techne Corporation; 20.5.1 Company Overview; 20.5.2 Products And Services; 20.6 Hologic, Inc; 20.6.1 Company Overview; 20.6.2 Products And Services; 20.7 Laboratory Corporation; 20.7.1 Company Overview; 20.7.2 Products And Services; 20.8 Siemens Healthineers; 20.8.1 Company Overview; 20.8.2 Products And Services; 20.9 Akonni Biosystems Inc; 20.9.1 Company Overview; 20.9.2 Products And Services; 20.10 Hain Lifescience GmbH; 20.10.1 Company Overview; 20.10.2 Products And Services; 20.11 Creative Diagnostics; 20.11.1 Company Overview; 20.11.2 Products And Services; 20.12 Lionex GmbH; 20.12.1 Company Overview; 20.12.2 Products And Services; 20.13 Genedrive PLC; 20.13.1 Company Overview; 20.13.2 Products And Services; 20.14 Mylab Discovery Solutions Pvt. Ltd; 20.14.1 Company Overview; 20.14.2 Products And Services; 20.15 AdvaCare Pharma; 20.15.1 Company Overview; 20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions: 23.1 Molbio Diagnostics Acquired Prognosys Medical Systems; 23.2 SD Biosensor Acquired Relab; 23.3 Hologic Inc. Acquired Mobidiag Oy; 23.4 PerkinElmer Acquired Oxford Immunotec; 23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.
24 Opportunities And Strategies: 24.1 Global Tuberculosis Diagnostics Market In 2028 – Countries Offering Most New Opportunities; 24.2 Global Tuberculosis Diagnostics Market In 2028 – Segments Offering Most New Opportunities; 24.3 Global Tuberculosis Diagnostics Market In 2028 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Tuberculosis Diagnostics Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer